<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03168802</url>
  </required_header>
  <id_info>
    <org_study_id>N201609021</org_study_id>
    <nct_id>NCT03168802</nct_id>
  </id_info>
  <brief_title>MRgFUS and RFA for Treatment of Facet-joint Osteoarthritis Low Back Pain</brief_title>
  <official_title>Comparative Study of Magnetic Resonance-guided Focused Ultrasound and Radiofrequency Ablation for Treatment of Facet-joint Osteoarthritis Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Taipei Medical University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Taipei Medical University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective, randomized, two-arm, phase II study.

      The purpose of this study is:

        -  To evaluate and compare the efficacy and safety of magnetic resonance-guided focused
           ultrasound (MRgFUS) and radiofrequency ablation (RFA) for treatment of facet-joint
           osteoarthritis low back pain.

        -  Determining the effect of the MRgFUS System and RFA for improving functional
           disabilities and in reducing pain resulting from facet-joint osteoarthritis low back
           pain. Efficacy will be determined by the level of pain relief (as measured by the
           Numerical Rating Scale, NRS), decrease in analgesics/opiate, improved quality of life
           (as measured by the Oswestry Disability Questionnaire, ODQ, and core outcome measures
           index questionnaire, COMI), pain interference with function (as measured by the Brief
           Pain Inventory-Interference scale, BPI-QoL), general health status (as measured by the
           EQ5D), physical exam, X-ray and MRI studies from baseline up to 12-Months post- MRgFUS
           and radiofrequency treatment.

        -  Evaluate incidence and severity of adverse events associated with the MRgFUS system and
           RFA used for the treatment of pain resulting from facet-joint osteoarthritis low back
           pain.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">April 21, 2017</start_date>
  <completion_date type="Anticipated">March 1, 2020</completion_date>
  <primary_completion_date type="Anticipated">March 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>50 patients in each arm.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score change: Numerical Rating Scale (NRS)</measure>
    <time_frame>24-week post-treatment</time_frame>
    <description>Efficacy</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pain score change: Numerical Rating Scale (NRS)</measure>
    <time_frame>1-, 4-, 8-, 12-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: Brief Pain Inventory-Quality of Life (BPI-QoL)</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: Oswestry Disability Questionnaire (ODQ)</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: Core Outcome Measurement Index (COMI)</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functional scales change: EQ5D Quality of Life questionnaires</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Amount of analgesic consumption</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse event</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Safety</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Physical exams for back range of motion</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </other_outcome>
  <other_outcome>
    <measure>X-ray for spine facet change</measure>
    <time_frame>1-, 4-, 8-, 12-, 24-, 36-, 52-week post-treatment</time_frame>
    <description>Efficacy</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <condition>Facet Joint Syndrome</condition>
  <arm_group>
    <arm_group_label>MRgFUS facet treatment</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>MRgFUS ablation for facet joint pain once at Lumbar spine</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radiofreuqency ablation facet treatment</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Radiofreuqency ablation for facet joint pain once at Lumbar spine</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>MRgFUS ablation</intervention_name>
    <description>Focus ultrasound ablation therapy under MRI navigation for facet joint syndrome.</description>
    <arm_group_label>MRgFUS facet treatment</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Radiofrequency ablation</intervention_name>
    <description>Radiofreuqency ablation therapy under C-arm navigation for facet joint syndrome.</description>
    <arm_group_label>Radiofreuqency ablation facet treatment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Men and women age 20 to 79 years old

          2. Suffering from lumbar vertebral facet joint syndrome.

          3. Lower back pain at least six months (NRSâ‰¥4).

          4. Conventional treatment of pain includes NSAIDs, opioids, muscle relaxants, oral
             steroids, physical therapy or chiropractic therapy.

          5. Imaging of the spine have facet osteoarthritis.

          6. Referred pain is no more below the knee.

          7. At least once when local anesthesia or diagnostic medial nerve branch injection, pain
             reduction&gt; 75% (0.5ml of 2% lidocaine).

        Exclusion Criteria:

          1. Patients with evidence of lumbosacral radiculopathy on MRI, CT or physical exam
             findings, including radicular leg pain.

          2. Patients with motor deficit or any other indication for surgical intervention.

          3. Patients with MRgFUS or RF treatment for LBP within the last 6 months.

          4. Patients with previous low back surgery.

          5. Patients who are pregnant.

          6. Patients with existing malignancy.

          7. Patients with allergies to relevant contrast, anesthetics, sedation drugs.

          8. Patients with contraindications for MRI.

          9. Patients with an acute medical condition (e.g., pneumonia, sepsis) that is expected to
             hinder them from completing this study.

         10. Patients with unstable cardiac status including:

               -  Unstable angina pectoris on medication

               -  Patients with documented myocardial infarction less than 40 days prior to
                  protocol enrolment

               -  Patients with Severe Congestive Heart Failure, NYHA class 4.

               -  Patients on anti-arrhythmic drugs or with uncontrolled and/or untreated
                  arrhythmia status

               -  Patients with pacemaker

         11. Patients with severe cerebrovascular disease (CVA within last 6 months)

         12. Patients with severe hypertension (diastolic BP &gt; 100 on medication)

         13. Patients with an active infection or severe hematological, neurological, or other
             uncontrolled disease.

         14. Patients unable to communicate with the investigator and staff.

         15. Patients who are not able or willing to tolerate the required prolonged stationary
             position during treatment (approximately 2 hrs.)

         16. Coagulation disorders or other bleeding disorders, use of anticoagulants or
             antiplatelet drugs within 5 days before treatment.

         17. When local anesthesia or diagnostic medial nerve branch injection, the pain does not
             reach 75% (0.5 mL of 2% lidocaine).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>79 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Yen Yun, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Taipei Medical University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Taipei medical university hospital</name>
      <address>
        <city>Taipei</city>
        <state>Please Select</state>
        <zip>11031</zip>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <reference>
    <citation>Weeks EM, Platt MW, Gedroyc W. MRI-guided focused ultrasound (MRgFUS) to treat facet joint osteoarthritis low back pain--case series of an innovative new technique. Eur Radiol. 2012 Dec;22(12):2822-35. doi: 10.1007/s00330-012-2628-6. Epub 2012 Aug 31.</citation>
    <PMID>22935902</PMID>
  </reference>
  <reference>
    <citation>Kaye EA, Monette S, Srimathveeravalli G, Maybody M, Solomon SB, Gulati A. MRI-guided focused ultrasound ablation of lumbar medial branch nerve: Feasibility and safety study in a swine model. Int J Hyperthermia. 2016 Nov;32(7):786-94. doi: 10.1080/02656736.2016.1197972. Epub 2016 Jul 21.</citation>
    <PMID>27443328</PMID>
  </reference>
  <reference>
    <citation>Krug R, Do L, Rieke V, Wilson MW, Saeed M. Evaluation of MRI protocols for the assessment of lumbar facet joints after MR-guided focused ultrasound treatment. J Ther Ultrasound. 2016 Apr 6;4:14. doi: 10.1186/s40349-016-0057-8. eCollection 2016.</citation>
    <PMID>27054038</PMID>
  </reference>
  <reference>
    <citation>Maas ET, Ostelo RW, Niemisto L, Jousimaa J, Hurri H, Malmivaara A, van Tulder MW. Radiofrequency denervation for chronic low back pain. Cochrane Database Syst Rev. 2015 Oct 23;(10):CD008572. doi: 10.1002/14651858.CD008572.pub2. Review.</citation>
    <PMID>26495910</PMID>
  </reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2017</study_first_submitted>
  <study_first_submitted_qc>May 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">May 30, 2017</study_first_posted>
  <last_update_submitted>August 8, 2017</last_update_submitted>
  <last_update_submitted_qc>August 8, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 10, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Taipei Medical University Hospital</investigator_affiliation>
    <investigator_full_name>Meng-Huang Wu</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Focused ultrasound Ablation</keyword>
  <keyword>Radiofrequency Ablation</keyword>
  <keyword>Facet joint syndrome</keyword>
  <keyword>Chronic low back pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

